SCHEDULE 13G: T. Rowe Price Associates Discloses 5.8% Beneficial Ownership in Perrigo Co PLC

T. Rowe Price Associates, Inc. has filed a Schedule 13G, reporting a 5.8% beneficial ownership stake in Perrigo Co PLC as of December 31, 2024.

Summary

• T. Rowe Price Associates, Inc. reported beneficial ownership of 7,845,539 shares of Perrigo Co PLC common stock.
• This ownership represents 5.8% of the total outstanding common stock of Perrigo Co PLC.
• T. Rowe Price Associates, Inc. holds sole voting power over 7,817,000 shares and sole dispositive power over all 7,845,539 shares.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Perrigo Co PLC.

Sentiment

Score: 7

Explanation: The disclosure of a significant stake by a major institutional investor like T. Rowe Price Associates is generally viewed positively as it signals confidence in the company, even though the filing itself is purely factual and not a performance report.

Positives

• The disclosure of a significant 5.8% stake by a major institutional investor like T. Rowe Price Associates, Inc. can signal strong institutional confidence in Perrigo Co PLC.
• The stated purpose of holding shares in the ordinary course of business, rather than for control, suggests a long-term investment perspective from a reputable asset manager.

Future Outlook

This Schedule 13G filing is a disclosure of current beneficial ownership and does not contain forward-looking statements or guidance regarding Perrigo Co PLC's future performance or T. Rowe Price Associates, Inc.'s future investment strategy.

Management Comments

• T. Rowe Price Associates, Inc. certified that the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

This filing represents a standard disclosure by a large institutional investment adviser, T. Rowe Price Associates, Inc., regarding its significant stake in Perrigo Co PLC, a company operating in the consumer health and pharmaceutical sector. Such disclosures are common and reflect ongoing investment activities by major asset managers in publicly traded companies.

Comparison to Industry Standards

• This filing is a routine regulatory disclosure of beneficial ownership by a large institutional investor. It does not provide performance metrics or operational results for comparison to industry standards or specific comparable companies. The 5.8% stake is a notable position for an institutional investor in a company of Perrigo's market capitalization.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by a major institutional investor may be perceived positively, potentially increasing investor confidence and demand for the stock.
• Company Management: Awareness of a large institutional holder may influence strategic decisions, though the filing explicitly states the stake is not for control purposes.

Next Steps

• No specific future actions or milestones for Perrigo Co PLC are mentioned in this filing, as it pertains to the reporting person's ownership stake. T. Rowe Price Associates, Inc. will continue to monitor its investment and file updates as required by SEC regulations.

Key Dates

Keywords

Perrigo Co PLC, T. Rowe Price Associates, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Pharmaceuticals, Consumer Health